Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are currently utilized in clinics for pulmonary inflammatory diseases, including acute respiratory distress syndrome and acute lung injury. Give...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakaş, Nihal, Üçüncüoğlu, Süleyman, Uludağ, Damla, Karaoğlan, Birnur Sinem, Shah, Khalid, Öztürk, Gürkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834073/
https://www.ncbi.nlm.nih.gov/pubmed/35159275
http://dx.doi.org/10.3390/cells11030465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834073/
https://www.ncbi.nlm.nih.gov/pubmed/35159275
http://dx.doi.org/10.3390/cells11030465

Ejemplares similares